The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 737K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

10 articles for BT Campbell


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of AC710, a Globally Selective Inhibitor of Platelet-Derived Growth Factor Receptor-Family Kinases.EBI
TBA
Identification of 1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea hydrochloride (CEP-32496), a highly potent and orally efficacious inhibitor of V-RAF murine sarcoma viral oncogene homologue B1 (BRAF) V600E.EBI
Ambit Biosciences
A quantitative analysis of kinase inhibitor selectivity.EBI
Ambit Biosciences
Expedited SAR study of high-affinity ligands to the alpha(2)delta subunit of voltage-gated calcium channels: Generation of a focused library using a solution-phase Sn2Ar coupling methodology.EBI
Merck Research Laboratories
Synthesis and biological evaluation of 6-aryl-6H-pyrrolo[3,4-d]pyridazine derivatives: high-affinity ligands to the alpha 2 delta subunit of voltage gated calcium channels.EBI
Merck Research Laboratories
4-Quinazolinyloxy-diaryl ureas as novel BRAFV600E inhibitors.EBI
Ambit Biosciences
Pyridin-2(1H)one derivatives, their preparation and their use for the treatment of painBDB
Inserm (Institut National De La Sante Et De La Recherche Medicale)
Trifluoromethylpropanamide derivatives as HTRA1 inhibitorsBDB
Hoffmann-La Roche
Monocyclic heteroaryl cycloalkyldiamine derivativesBDB
Novartis
Cyclic ether DGAT1 inhibitorscyclic ether DGAT1 inhibitorsBDB
Novartis